<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03560921</url>
  </required_header>
  <id_info>
    <org_study_id>KA-13115</org_study_id>
    <nct_id>NCT03560921</nct_id>
  </id_info>
  <brief_title>Urinary NGAL Acute Kidney Injury After Stored Red Blood Cells Transfusion in Critically Ill Patients.</brief_title>
  <official_title>The Association of NGAL With the Development of Acute Kidney Injury After Stored Red Blood Cells Transfusion in Critically Ill Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to explore the association of the novel urinary bio marker NGAL with the age
      of PRBCs(packed red blood cells) transfusion in critically ill patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will measure the urinary NGAL in all patients who received blood
      transfusion in the intensive care unit during the study period. The age of PRBCs transfusion
      will be correlated with the incidence of AKI. The rise of NGAL and serum creatinine will be
      used to diagnose AKI (Acute Kidney Injury).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2, 2017</start_date>
  <completion_date type="Actual">December 5, 2017</completion_date>
  <primary_completion_date type="Actual">December 5, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of AKI</measure>
    <time_frame>within 30 days</time_frame>
    <description>Diagnosis of AKI by rise of serum creatinine</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">147</enrollment>
  <condition>Acute Kidney Injury</condition>
  <condition>Anemia</condition>
  <arm_group>
    <arm_group_label>Stored blood transfusion</arm_group_label>
    <description>measurement of urinary NGAL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fresh blood transfusion</arm_group_label>
    <description>measurement of urinary NGAL</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>urinary NGAL</intervention_name>
    <description>measurement urinary NGAL using the ARCHITECT technique</description>
    <arm_group_label>Fresh blood transfusion</arm_group_label>
    <arm_group_label>Stored blood transfusion</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urine samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients admitted to ICU of any age and sex
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patients admitted to the intensive care unit.

        Exclusion Criteria:

          -  patients who have established AKI at the time of recruitment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tarek Abdelaziz</last_name>
    <role>Principal Investigator</role>
    <affiliation>faculty of medicine-Cairo University Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cairo university hospitals</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 5, 2018</study_first_submitted>
  <study_first_submitted_qc>June 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2018</study_first_posted>
  <last_update_submitted>June 15, 2018</last_update_submitted>
  <last_update_submitted_qc>June 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>Tarek Samy Abdelziz</investigator_full_name>
    <investigator_title>Senior lecturer</investigator_title>
  </responsible_party>
  <keyword>biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

